 News
10th February 2007
New test for newborn babies
All newborn babies in England are to be tested for a rare but potentially
fatal disease.
Government advisors have said that the test for a metabolic
disease called Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD)
will be performed as part of the heel prick test which tests for other
diseases such as sickle cell.
MCADD affects between one in 10,000 and one in 20,000 babies
born in the UK.
The disease kills around a quarter of children diagnosed,
and a third of survivors are left with severe neurological damage.
However, if caught early enough, simple treatment dramatically
reduces these complications.
The test, which will be introduced across England over the
next two years, will detect 28 cases a year.
The test has been piloted throughout the UK and although
the final report is not due until 2008, the Department of Health has confirmed
that enough evidence has arisen for the screening to be recommended now.
Announcing the extra check, health minister Ivan Lewis said,
"I am delighted that all newborn babies will be screened for MCADD.
"Not only will the introduction of this screening programme
save lives it will improve the quality of life for those children affected
by this condition."
Dr Sheila Shribman, National Clinical Director for Children,
Young People and Maternity Services, added, "This is a very important
screening programme and I fully support its implementation.
"Evidence shows that screening newborn babies for this condition
will not only save lives but it can significantly improve their quality
of life.
"Simple treatment through dietary management will substantially
reduce the risk of death and the risk of acute, serious illness."
Where to next?
|
